H2-M3-restricted CD8+ T cells induced by peptide-pulsed dendritic cells confer protection against Mycobacterium tuberculosis

Journal of Immunology

Volumn 178, Issue 6, 2007, Pages 3806-3813

  Doi, Takehiko ^a,b   Yamada, Hisakata ^a   Yajima, Toshiki ^a   Wajjwalku, Worawidh ^c   Hara, Toshiro ^b   Yoshikai, Yasunobu ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KASETSART UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CD8 ANTIGEN; CYTOKINE; H2 M3 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PROTEIN MPT64[190-198]; PROTEIN TB2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; IMMUNIZATION; LUNG; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

EID: 33947240252     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.6.3806     Document Type: Article

References (40)

1. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement: global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. J. Am. Med. Assoc. 282: 677-686.
2. Lanckriet, C., D. Levy-Bruhl, E. Bingono, R. M. Siopathis, and N. Guerin. 1995. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui. Int. J. Epidemiol. 24: 1042-1049.
3. Colditz, G. A., C. S. Berkey, F. Mosteller, T. F. Brewer, M. E. Wilson, E. Burdick, and H. V. Fineberg. 1995. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 96: 29-35.
4. Mittel, S. K., V. Aggarwal, A. Rastogi, and N. Saini. 1996. Does B.C.G. vaccination prevent or postpone the occurrence of tuberculous meningitis? Indian J. Pediatr. 63: 659-664.
5. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. J. Am. Med. Assoc. 271: 698-702.
6. Kaufmann, S. H. 2006. Tuberculosis: back on the immunologists' agenda. Immunity 24: 351-357.
7. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19: 93-129.
8. Kaufmann, S. H. 2001. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol 1: 20-30.
9. + T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 95: 270-275.
10. Sousa, A. O., R. J. Mazzaccaro, R. G. Russell, F. K. Lee, O. C. Turner, S. Hong, L. Van Kaer, and B. R. Bloom. 2000. Relative contributions of distinct MHC class 1-dependent cell populations in protection to tuberculosis infection in mice. Proc. Natl. Acad. Sci. USA 97: 4204-4208.
11. Flynn, J. L., M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89: 12013-12017.
12. Orme, I. M. 1987. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J. Immunol. 138: 293-298.
13. + T-cell memory and prime-boost response after dendritic-cell vaccination. Nat. Med. 11: 748-756.
14. + T cell expansion, memory, and protective immunity after immunization with peptide-coated dendritic cells. J. Immunol. 169: 4936-4944.
15. Steinman, R. M., and M. Pope. 2002. Exploiting dendritic cells to improve vaccine efficacy. J. Clin. Invest. 109: 1519-1526.
16. Nakano, H., T. Nagata, T. Suda, T. Tanaka, T. Aoshi, M. Uchijima, S. Kuwayama, N. Kanamaru, K. Chida, H. Nakamura, et al. 2006. Immunization with dendritic cells retrovirally transduced with mycobacterial antigen 85A gene elicits the specific cellular immunity including cytotoxic T-lymphocyte activity-specific to an epitope on antigen 85A. Vaccine 24: 2110-2119.
17. Malowany, J. I., S. McCormick, M. Santosuosso, X. Zhang, N. Aoki, P. Ngai, J. Wang, J. Leitch, J. Bramson, Y. Wan, and Z. Xing. 2005. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts. Mol. Ther. 13: 766-775.
18. +-T-cell epitopes from antigen 85A. Infect. Immun. 70: 1623-1626.
19. Banchereau, J., and A. K. Palucka. 2005. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5: 296-306.
20. Gulden, P. H., P. Fischer III, N. E. Sherman, W. Wang, V. H. Engelhard, J. Shabanowitz, D. F. Hunt, and E. G. Pamer. 1996. A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. Immunity 5: 73-79.
21. Wong, P., and E. G. Pamer. 2003. CDS T cell responses to infectious pathogens. Annu. Rev. Immunol. 21: 29-70.
22. Rodgers, J. R., and R. G. Cook. 2005. MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 5: 459-471.
23. Chun, T., N. V. Serbina, D. Nolt, B. Wang, N. M. Chin, J. L. Flynn, and C. R. Wang. 2001. Induction of MS-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis. J. Exp. Med. 193: 1213-1220.
24. Lauvau, G., and E. G. Pamer. 2001. CD8 T cell detection of bacterial infection: sniffing for formyl peptides derived from Mycobacterium tuberculosis. J. Exp. Med. 193: F35-F39.
25. + T cells with specificity for a novel mycobacterial epitope. Int. Immunol. 13: 451-458.
26. Harboe, M., S. Nagai, M. E. Patarroyo, M. L. Torres, C. Ramirez, and N. Cruz. 1986. Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG. Infect. Immun. 52: 293-302.
27. Roche, P. W., J. A. Triccas, D. T. Avery, T. Fifis, H. Billman-Jacobe, and W. J. Britton. 1994. Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guerin from infection with Mycobacterium tuberculosis. J. Infect. Dis. 170: 1326-1330.
28. Skeiky, Y. A., M. R. Alderson, P. J. Ovendale, J. A. Guderian, L. Brandt, D. C. Dillon, A. Campos-Neto, Y. Lobet, W. Dalemans, I. M. Orme, and S. G. Reed. 2004. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J. Immunol. 172: 7618-7628.
29. Skeiky, Y. A., M. J. Lodes, J. A. Guderian, R. Mohamath, T. Bernent, M. R. Alderson, and S. G. Reed. 1999. Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis. Infect. Immun. 67: 3998-4007.
30. + T cells from subunit-vaccinated and infected H-2b mice recognizing the 38 kDa antigen of Mycobacterlum tuberculosis. Int. Immunol. 9: 1669-1676.
31. Dow, S. W., A. Roberts, J. Vyas, J. Rodgers, R. R. Rich, I. Orme, and T. A. Potter. 2000. Immunization with f-Met peptides induces immune reactivity against Mycobacterium tuberculosis. Tuber. Lung Dis. 80: 5-13.
32. Wang, C. R., A. R. Castano, P. A. Peterson, C. Slaughter, K. F. Lindahl, and J. Deisenhofer. 1995. Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3. Cell 82: 655-664.
33. Dabhi, V. M., and K. F. Lindahl. 1998. Short peptides sensitize target cells to CTL specific for the MHC class Ib molecule, H2-M3. Eur. J. Immunol. 28: 3773-3782.
34. Xu, H., T. Chun, H. J. Choi, B. Wang, and C. R. Wang. 2006. Impaired response to Listeria in H2-M3-deficient mice reveals a nonredundant role of MHC class Ib-specific T cells in host defense. J. Exp. Med. 203: 449-459.
35. Kerksiek, K. M., D. H. Busch, I. M. Pilip, S. E. Allen, and E. G. Pamer. 1999. H2-M3-restricted T cells in bacterial infection: rapid primary but diminished memory responses. J. Exp. Med. 190: 195-204.
36. Seaman, M. S., C. R. Wang, and J. Forman. 2000. MHC class Ib-restricted CTL provide protection against primary and secondary Listeria monocytogenes infection. J. Immunol. 165: 5192-5201.
37. Levitt, J. M., D. D. Howell, J. R. Rodgers, and R. R. Rich. 2001. Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules. Eur. J. Immunol. 31: 1181-1190.
38. Chiu, N. M., T. Chun, M. Fay, M. Mandal, and C. R. Wang. 1999. The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides. J. Exp. Med. 190: 423-434.
39. Sturgill-Koszycki, S., P. H. Schlesinger, P. Chakraborty, P. L. Haddix, H. L. Collins, A. K. Fok, R. D. Allen, S. L. Gluck, J. Heuser, and D. G. Russell. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263: 678-681.
40. Clemens, D. L., and M. A. Horwitz. 1995. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med. 181: 257-270.